1. CTNI-03. A PHASE I/IIA, OPEN-LABEL STUDY OF THE BRAIN-PENETRANT PARP1-SELECTIVE INHIBITOR AZD9574 AS MONOTHERAPY AND IN COMBINATION IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES (CERTIS1). (14th November 2022) Authors: Mueller, Nancy; Luen, Stephen; Stupp, Roger; Chalmers, Anthony; Huang, Baisong; Squatrito, Massimo; Davies, Barry; Hamerlik, Petra; Yap, Timothy Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Durvalumab activity in previously treated patients who stopped durvalumab without disease progression. Issue 2 (26th August 2020) Authors: Sheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗